Dallah Healthcare Company SJSC
SAU:4004
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
154.2
188
|
| Price Target |
|
We'll email you a reminder when the closing price reaches SAR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Dallah Healthcare Company SJSC
Dallah Healthcare Company SJSC
Cost of Revenue
Dallah Healthcare Company SJSC
Cost of Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Dallah Healthcare Company SJSC
SAU:4004
|
Cost of Revenue
-ď·Ľ1.9B
|
CAGR 3-Years
-20%
|
CAGR 5-Years
-20%
|
CAGR 10-Years
-15%
|
|
|
National Medical Care Company JSC
SAU:4005
|
Cost of Revenue
-ď·Ľ753.8m
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-4%
|
|
|
Mouwasat Medical Services Company SJSC
SAU:4002
|
Cost of Revenue
-ď·Ľ1.5B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
-12%
|
|
|
A
|
Al Hammadi Holding Co
SAU:4007
|
Cost of Revenue
-ď·Ľ744.6m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
-11%
|
|
|
Dr Sulaiman Al-Habib Medical Services Group Co
SAU:4013
|
Cost of Revenue
-ď·Ľ6.2B
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
N/A
|
|
|
D
|
Dr Soliman Abdel Kader Fakeeh Hospital Company SCJSC
SAU:4017
|
Cost of Revenue
-ď·Ľ1.7B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Dallah Healthcare Company SJSC
Glance View
Dallah Healthcare Co. engages in the provision and operation of healthcare programs and utilities. The company is headquartered in Riyadh, Riyadh. The company went IPO on 2012-12-16. The firm operates in the following business segments: Hospitals; Medicines, and Head Office. The Hospitals’ segment objectives are to own, manage, operate and maintain healthcare facilities. The Medicines’ segment objectives are to import, distribute, wholesale and retail medicines, as well as manufacture medicines, pharmaceuticals, herbals, health, cosmetics, detergents, disinfectants, and packaging materials. The Head Office’s segment objectives are to operate, manage and maintain healthcare facilities; wholesale and retail surgical equipment, artificial parts, handicapped and hospitals equipment, as well as other supporting services.
See Also
What is Dallah Healthcare Company SJSC's Cost of Revenue?
Cost of Revenue
-1.9B
SAR
Based on the financial report for Jun 30, 2024, Dallah Healthcare Company SJSC's Cost of Revenue amounts to -1.9B SAR.
What is Dallah Healthcare Company SJSC's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-15%
Over the last year, the Cost of Revenue growth was 11%. The average annual Cost of Revenue growth rates for Dallah Healthcare Company SJSC have been -20% over the past three years , -20% over the past five years , and -15% over the past ten years .
You don't have any saved screeners yet
